| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.346 | 3.538 | 5.065 | 4.430 | 4.719 | 7.855 | 5.748 | 6.201 | 4.469 |
| Total Income - EUR | - | 4.346 | 3.543 | 5.065 | 4.431 | 4.719 | 7.855 | 5.748 | 6.201 | 4.469 |
| Total Expenses - EUR | - | 60 | 797 | 391 | 347 | 322 | 311 | 315 | 347 | 386 |
| Gross Profit/Loss - EUR | - | 4.286 | 2.746 | 4.674 | 4.084 | 4.396 | 7.544 | 5.433 | 5.854 | 4.083 |
| Net Profit/Loss - EUR | - | 4.155 | 2.640 | 4.522 | 3.951 | 4.260 | 7.309 | 5.261 | 4.917 | 3.430 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Respimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 73 | 1.798 | 1.503 | 1.232 | 966 | 714 | 484 | 251 | 19 |
| Current Assets | - | 4.199 | 4.329 | 7.121 | 3.032 | 4.814 | 11.300 | 12.932 | 17.697 | 20.435 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.178 | 0 | 258 | 0 | 894 | 1.162 | 608 | 0 | 0 |
| Cash | - | 3.022 | 4.329 | 6.863 | 3.032 | 3.920 | 10.138 | 12.324 | 17.697 | 20.435 |
| Shareholders Funds | - | 4.200 | 2.684 | 4.573 | 4.001 | 4.309 | 7.357 | 5.309 | 4.965 | 3.478 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 73 | 3.443 | 4.051 | 262 | 1.472 | 4.657 | 8.107 | 12.983 | 16.976 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Respimed Srl